CG
HZNP

Cutler Group’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Cutler Group’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-1,600
Closed -$14K – 4599
2023
Q3 		$14K Sell
1,600
-23,600
-94% -$2.54M ﹤0.01% 2303
2023
Q2 		$80K Buy
25,200
+24,800
+6,200% +$2.62M 0.01% 1042
2023
Q1 		$3K Sell
400
-36,900
-99% -$4.08M ﹤0.01% 3059
2022
Q4 		$217K Buy
37,300
+36,800
+7,360% +$3.06M 0.02% 754
2022
Q3 		$1K Buy
+500
New +$34.9K ﹤0.01% 4817
2022
Q2 		– Sell
-31,200
Closed -$206K – 6067
2022
Q1 		$206K Buy
31,200
+30,400
+3,800% +$2.96M 0.01% 1168
2021
Q4 		$34K Sell
800
-5,600
-88% -$611K ﹤0.01% 2716
2021
Q3 		$11K Buy
+6,400
New +$664K ﹤0.01% 3895
2021
Q2 		– Sell
-5,500
Closed -$19K – 6771
2021
Q1 		$19K Buy
5,500
+4,500
+450% +$380K ﹤0.01% 3282
2020
Q4 		$2K Buy
+1,000
New +$74.3K ﹤0.01% 4330
2020
Q3 		– Sell
-1,200
Closed -$9K – 5538
2020
Q2 		$9K Buy
+1,200
New +$51.3K ﹤0.01% 2984
2018
Q1 		– Sell
-10,300
Closed -$1K – 5701
2017
Q4 		$1K Sell
10,300
-3,700
-26% -$52K ﹤0.01% 4718
2017
Q3 		$5K Sell
14,000
-6,700
-32% -$85.2K ﹤0.01% 4478
2017
Q2 		$10K Sell
20,700
-35,800
-63% -$445K ﹤0.01% 4216
2017
Q1 		$21K Sell
56,500
-213,200
-79% -$3.45M ﹤0.01% 3304
2016
Q4 		$47K Buy
269,700
+170,000
+171% +$3.08M ﹤0.01% 2614
2016
Q3 		$121K Buy
99,700
+63,300
+174% +$1.24M 0.01% 1667
2016
Q2 		$36K Sell
36,400
-13,200
-27% -$214K ﹤0.01% 2720
2016
Q1 		$29K Sell
49,600
-125,300
-72% -$2.19M ﹤0.01% 2897
2015
Q4 		$268K Buy
+174,900
New +$3.4M 0.02% 956

Other funds holding HZNP

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
VWA
Valued Wealth Advisors Holladay, Utah $275M AUM 24.94% 1-Year Est. Return
FSWA
Financial Synergies Wealth Advisors Houston, Texas $1.18B AUM 31.41% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $683M AUM 22.58% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Cutler Group's HZNP Position: Q4 2023 in Review

Cutler Group sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 6,450 shares — an estimated $746K sold.

Cutler Group first reported a position in HZNP in Q4 2015 and held it in 27 quarters. The position peaked at $3.19M in Q1 2022. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

  • Cutler Group reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
  • Cutler Group sold 6,450 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $746K.
  • Cutler Group first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2015 and held it in 27 quarters.
  • Cutler Group's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $3.19M in Q1 2022.
  • 6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on Cutler Group's 13F filing for Q4 2023, filed 18 Jan 2024.